| pubmed-article:12065557 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12065557 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12065557 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:12065557 | lifeskim:mentions | umls-concept:C0036751 | lld:lifeskim |
| pubmed-article:12065557 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:12065557 | lifeskim:mentions | umls-concept:C0010762 | lld:lifeskim |
| pubmed-article:12065557 | lifeskim:mentions | umls-concept:C0003297 | lld:lifeskim |
| pubmed-article:12065557 | lifeskim:mentions | umls-concept:C0017431 | lld:lifeskim |
| pubmed-article:12065557 | lifeskim:mentions | umls-concept:C0243076 | lld:lifeskim |
| pubmed-article:12065557 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:12065557 | pubmed:dateCreated | 2002-6-14 | lld:pubmed |
| pubmed-article:12065557 | pubmed:abstractText | The use of serotonin 5-hydroxytryptamine type 3 receptor antagonists has substantially reduced, but not eliminated, nausea and vomiting in cancer chemotherapy. This study sought to investigate whether efficacy of antiemetic treatment with ondansetron and tropisetron depends on cytochrome P-450 2D6 (CYP2D6) genotype, hypothesizing that the rapid and particularly the ultrarapid metabolizers of these drugs are at risk of being undertreated. | lld:pubmed |
| pubmed-article:12065557 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12065557 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12065557 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12065557 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12065557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12065557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12065557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12065557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12065557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12065557 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12065557 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12065557 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12065557 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:SezerOrhanO | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:PossingerKurt... | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:BrockmöllerJü... | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:BauerSteffenS | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:RootsIvarI | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:KaiserRolfR | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:TremblayPierr... | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:PapiesAnjaA | lld:pubmed |
| pubmed-article:12065557 | pubmed:author | pubmed-author:SchelenzClaud... | lld:pubmed |
| pubmed-article:12065557 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12065557 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:12065557 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:12065557 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12065557 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12065557 | pubmed:pagination | 2805-11 | lld:pubmed |
| pubmed-article:12065557 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:meshHeading | pubmed-meshheading:12065557... | lld:pubmed |
| pubmed-article:12065557 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12065557 | pubmed:articleTitle | Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes. | lld:pubmed |
| pubmed-article:12065557 | pubmed:affiliation | Institute of Clinical Pharmacology and Department of Hematology and Oncology, University Medical Center Charité, Humboldt University of Berlin, Berlin, Germany. rolf.kaiser@med.uni-goettingen.de | lld:pubmed |
| pubmed-article:12065557 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12065557 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12065557 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:1565 | entrezgene:pubmed | pubmed-article:12065557 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12065557 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12065557 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12065557 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12065557 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12065557 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12065557 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12065557 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12065557 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12065557 | lld:pubmed |
